|
LRIG2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.697500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.587400E-01 |
| Normal-vs-Stage2 |
4.640500E-02 |
| Normal-vs-Stage3 |
2.381200E-03 |
| Normal-vs-Stage4 |
1.629520E-04 |
| Stage1-vs-Stage2 |
1.990810E-01 |
| Stage1-vs-Stage3 |
2.393900E-02 |
| Stage1-vs-Stage4 |
3.561400E-03 |
| Stage2-vs-Stage3 |
7.094600E-01 |
| Stage2-vs-Stage4 |
2.717200E-01 |
| Stage3-vs-Stage4 |
3.823600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.744500E-03 |
| Normal-vs-AfricanAmerican |
3.000400E-01 |
| Normal-vs-Asian |
2.402400E-04 |
| Caucasian-vs-AfricanAmerican |
4.607400E-01 |
| Caucasian-vs-Asian |
2.023800E-04 |
| AfricanAmerican-vs-Asian |
6.257200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.183600E-04 |
| Normal-vs-Female |
3.784400E-01 |
| Male-vs-Female |
7.500300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.749600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.770300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.582300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.410420E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.633200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.353400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.031400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.442800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.331600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.832000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.099500E-02 |
| Normal-vs-Grade 2 |
4.247400E-01 |
| Normal-vs-Grade 3 |
5.583200E-04 |
| Normal-vs-Grade 4 |
2.85870000005239E-07 |
| Grade 1-vs-Grade 2 |
1.129580E-02 |
| Grade 1-vs-Grade 3 |
4.12029999999897E-05 |
| Grade 1-vs-Grade 4 |
1.89340000011917E-07 |
| Grade 2-vs-Grade 3 |
4.095700E-03 |
| Grade 2-vs-Grade 4 |
1.78049999999264E-06 |
| Grade 3-vs-Grade 4 |
1.744490E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.371200E-01 |
| Normal-vs-ccB subtype |
2.162900E-03 |
| ccA subtype-vs-ccB subtype |
2.123700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.746100E-02 |
| Normal-vs-N1 |
3.218800E-04 |
| N0-vs-N1 |
3.777700E-02 |
|
|
